Clinical Trial: Perioperative treatment patterns and outcomes by risk of recurrence for patients with HER2-positive early breast cancer; A retrospective database study in Japan (Japan)

Tokyo, May 30 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061730) titled 'Perioperative treatment patterns and outcomes by risk of recurrence for patients with HER2-positive early breast cancer; A retrospective database study in Japan' on May 30.

Study Type: Others,meta-analysis etc

Primary Sponsor: Institute - Daiichi Sankyo Co., Ltd.

Condition: Condition - HER2 positive breast cancer Classification by malignancy - Malignancy Genomic information - NO

Objective: Narrative objectives1 - To use a database to assess the implementation and efficacy of perioperative treatment for HER2-positive breast cancer patients stratified by disease stage Basic objectives2 - Others

Eligibility: Age-lower limit - 18 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - 1.Patients newly diagnosed with breast cancer between 1 October 2018 and 30 September 2024 2.Aged 18 years or older at the date of breast cancer diagnosis 3.Patients with breast cancer in clinical stage I to III 4.Patients with HER2-positive breast cancer 5. Underwent curative surgery for breast cancer during the period from the date of breast cancer diagnosis until 30 September 2024 Key exclusion criteria - 1.Has a history of diagnosis of cancer other than breast cancer prior to the diagnosis of breast cancer

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 05 Month 18 Day Anticipated trial start date - 2026 Year 07 Month 01 Day Last follow-up date - 2026 Year 12 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070651

Disclaimer: Curated by HT Syndication.